Renaissance Technologies
OCAT

Renaissance Technologies’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Renaissance Technologies’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-54,900
Closed -$462K – 3695
2015
Q4 		$462K Buy
+54,900
New +$367K ﹤0.01% 2760

Renaissance Technologies's OCAT Position: Q1 2016 in Review

Renaissance Technologies sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 54,900 shares — an estimated $462K sold.

Renaissance Technologies first reported a position in OCAT in Q4 2015 and held it in 1 quarter. The position peaked at $462K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Renaissance Technologies reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Renaissance Technologies sold 54,900 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $462K.
  • Renaissance Technologies first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q4 2015 and held it in 1 quarter.
  • Renaissance Technologies's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $462K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.